Hobyung Chung

4.1k total citations · 1 hit paper
77 papers, 3.3k citations indexed

About

Hobyung Chung is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hobyung Chung has authored 77 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hepatology, 42 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Hobyung Chung's work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (38 papers) and Hepatitis C virus research (17 papers). Hobyung Chung is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (38 papers) and Hepatitis C virus research (17 papers). Hobyung Chung collaborates with scholars based in Japan, China and United States. Hobyung Chung's co-authors include Masatoshi Kudo, Yukio Osaki, Yasunori Minami, Tatsuo Inoue, Toshihiko Kawasaki, Taisuke Ueda, Satoshi Kitai, Kazuomi Ueshima, Satoru Hagiwara and Kiyoshi Maekawa and has published in prestigious journals such as Hepatology, Radiology and The Journal of Infectious Diseases.

In The Last Decade

Hobyung Chung

73 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)

2003 555 citations Masatoshi Kudo, Hobyung Chung et al. Journal of Gastroenterology profile →

Peers

Countries citing papers authored by Hobyung Chung

Since Specialization

Citations

This map shows the geographic impact of Hobyung Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hobyung Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hobyung Chung more than expected).

Fields of papers citing papers by Hobyung Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hobyung Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hobyung Chung. The network helps show where Hobyung Chung may publish in the future.

Co-authorship network of co-authors of Hobyung Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Hobyung Chung. A scholar is included among the top collaborators of Hobyung Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hobyung Chung. Hobyung Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	STANDARD VS. COMPUTER-AIDED DETECTION ASSISTED COLONOSCOPY FOR DETECTION OF COLORECTAL NEOPLASIA: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL	Gastrointestinal Endoscopy	Yohei Yabuuchi, Takuya Kobayashi et al.	0
2	Autoimmune hepatitis and IgG4-related disease	World Journal of Gastroenterology	Kosuke Minaga, Tomohiro Watanabe et al.	33
3	Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis	Journal of Pharmaceutical Health Care and Sciences	Hiroaki Ikesue, Kazumi Fujita et al.	6
4	Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy	Digestion	Masahiro Takita, Satoru Hagiwara et al.	6
5	Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan	Intervirology	Hobyung Chung, Taisuke Ueda et al.	125
6	PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate	Intervirology	Norihisa Yada, Masatoshi Kudo et al.	6
7	The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma	Journal of Gastroenterology	Satoru Hagiwara, Masatoshi Kudo et al.	12
8	Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience	Liver International	Yasunori Minami, Masatoshi Kudo et al.	46
9	Hepatitis C Virus Core Protein Induces Homotolerance and Cross‐Tolerance to Toll‐Like Receptor Ligands by Activation of Toll‐Like Receptor 2	The Journal of Infectious Diseases	Hobyung Chung, Tomohiro Watanabe et al.	49
10	Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma	Oncology	Kinuyo Hatanaka, Hobyung Chung et al.	28
11	Identification and characterization of IgG4-associated autoimmune hepatitis	Liver International	Hobyung Chung, Tomohiro Watanabe et al.	72
12	Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC	Journal of Hepatology	Hidenori Toyoda, Takashi Kumada et al.	85
13	Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid	Oncology	Tatsuo Inoue, Masatoshi Kudo et al.	32
14	Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy	Oncology	Shunsuke Takahashi, Masatoshi Kudo et al.	74
15	Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation	Oncology	Masatoshi Kudo, Yasuhiro Sakaguchi et al.	54
16	Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation	Digestive Diseases	Shunsuke Takahashi, Masatoshi Kudo et al.	26
17	Multiple metastases from a meningeal hemangiopericytoma associated with severe hypoglycemia	Journal of Medical Ultrasonics	Pei Zhou, Masatoshi Kudo et al.	2
18	Hemodynamic and morphologic changes of peripheral hepatic vasculature in chronic liver disease: a preliminary study by contrast-enhanced coded phase-inversion harmonic sonography	Journal of Medical Ultrasonics	Yasuhiro Sakaguchi, Masatoshi Kudo et al.	1
19	Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) breakdown →	Journal of Gastroenterology	Masatoshi Kudo, Hobyung Chung et al.	555
20	Evaluation of Posttreatment Response of Hepatocellular Carcinoma with Contrast-enhanced Coded Phase-Inversion Harmonic US: Comparison with Dynamic CT	Radiology	Hong Ding, Masatoshi Kudo et al.	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact